0001847903 2025-01-01 2025-12-31 false 0001847903 DEF 14A CENTESSA PHARMACEUTICALS PLC true <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">It is not the current practice or policy of the Compensation Committee or the Company to either take material nonpublic information, or MNPI, into account when determining the timing and terms of an option award or similar award or to time the disclosure of MNPI for the purpose of affecting the value of executive compensation. Specifically, equity awards are typically granted annually in the first quarter of the year. Equity awards may occasionally be granted off-cycle, including awards to new hires. In 2025, we did not grant an option or option-like award to a named executive officer during the period beginning four business days before and ending one business day after the filing or furnishing of a Form 10-Q, Form 10-K or Form 8-K that discloses MNPI.</span></div> It is not the current practice or policy of the Compensation Committee or the Company to either take material nonpublic information, or MNPI, into account when determining the timing and terms of an option award or similar award or to time the disclosure of MNPI for the purpose of affecting the value of executive compensation. Specifically, equity awards are typically granted annually in the first quarter of the year. false true